Insider Trades64 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 30,000 | $17.96 | $2.0B | -7.31% | +137.30% | $538.9K | -7.44% | 10b5-1 | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 6,461 | $14.58 | $2.0B | -7.31% | +137.30% | $94.2K | -3.68% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 6,844 | $14.52 | $2.0B | -7.31% | +137.30% | $99.4K | -4.84% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | James M Frates | Chief Financial Officer | 7,909 | $14.52 | $2.0B | -7.31% | +137.30% | $114.9K | -4.56% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 29,282 | $14.47 | $2.0B | -7.31% | +137.30% | $423.8K | -0.87% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 29,282 | $14.48 | $2.0B | -7.31% | +137.30% | $424.1K | -0.87% | — | Buy Now |
| Feb 23, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 3,419 | $14.14 | $2.0B | -7.31% | +137.30% | $48.4K | -2.36% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 3,448 | $14.65 | $2.0B | -7.31% | +137.30% | $50.5K | -2.33% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | James M Frates | Chief Financial Officer | 3,557 | $14.65 | $2.0B | -7.31% | +137.30% | $52.1K | -2.01% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 15,500 | $14.68 | $2.0B | -7.31% | +137.30% | $227.6K | -0.46% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 15,500 | $14.69 | $2.0B | -7.31% | +137.30% | $227.6K | -0.46% | — | Buy Now |
| Jan 15, 2026 | Buy | AMLX | Justin B. Klee | Co-Chief Executive Officer | 338,188 | $10.03 | $2.0B | -7.31% | +137.30% | $3.4M | +0.45% | — | Buy Now |
| Jan 15, 2026 | Buy | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 338,167 | $10.03 | $2.0B | -7.31% | +137.30% | $3.4M | +0.45% | — | Buy Now |
| Jan 6, 2026 | Sell | AMLX | James M Frates | Chief Financial Officer | 3,326 | $11.11 | $2.0B | -7.31% | +137.30% | $37.0K | -1.84% | — | Buy Now |
| Jan 6, 2026 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 7,715 | $11.09 | $2.0B | -7.31% | +137.30% | $85.6K | -0.23% | — | Buy Now |
| Jan 6, 2026 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 7,715 | $11.09 | $2.0B | -7.31% | +137.30% | $85.6K | -0.23% | — | Buy Now |
| Dec 1, 2025 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 6,580 | $14.35 | $2.0B | -7.31% | +137.30% | $94.4K | -3.61% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 8,828 | $14.58 | $2.0B | -7.31% | +137.30% | $128.7K | -5.62% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | James M Frates | Chief Financial Officer | 10,558 | $14.65 | $2.0B | -7.31% | +137.30% | $154.7K | -3.63% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 12,039 | $14.58 | $2.0B | -7.31% | +137.30% | $175.5K | -6.19% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 29,933 | $14.35 | $2.0B | -7.31% | +137.30% | $429.5K | -0.45% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 29,975 | $14.38 | $2.0B | -7.31% | +137.30% | $431.0K | -0.45% | — | Buy Now |
| Aug 12, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 30,000 |